US Patent Issued to STRM.bio on Jan. 13 for "Compositions and methods related to megakaryocyte-derived extracellular vesicles for Fanconi Anemia" (Massachusetts Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,449, issued on Jan. 13, was assigned to STRM.bio Inc. (Cambridge, Mass.).

"Compositions and methods related to megakaryocyte-derived extracellular vesicles for Fanconi Anemia" was invented by Jonathan Thon (Cambridge, Mass.), David Raiser (Cambridge, Mass.) and Laura Goldberg (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions and methods related to megakaryocyte-derived extracellular vesicles derived from human pluripotent stem cells, where the megakaryocyte-derived extracellular vesicles may be utilized for treating Fanconi anemia (FA)."

The patent was filed on April 26, 2022, under Application No. 1...